FDA Approves Eagle Pharmaceuticals' Ryanodex For The Treatment Of Malignant Hyperthermia
July 23, 2014 at 07:05 AM EDT
Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (Nasdaq: EGRX) today announced that the U. S. Food and Drug Administration (FDA) ...